A phase I/II trial of induction cisplatin and docetaxel followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for locally advanced squamous cell carcinoma of the head and neck

Trial Profile

A phase I/II trial of induction cisplatin and docetaxel followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for locally advanced squamous cell carcinoma of the head and neck

Completed
Phase of Trial: Phase I/II

Latest Information Update: 14 Feb 2011

At a glance

  • Drugs Amifostine; Cisplatin; Docetaxel
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2011 Aventis Pharmaceuticals as company and lead trial centres identified as reported by ClinicalTrials.gov.
    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top